Read twice and referred to the Committee on Finance.
The bill requires Medicare Advantage (MA) plans that use prior authorization to implement standardized electronic prior authorization (ePA) by 2028, meet transparency reporting by 2027, and adopt enrollee protection standards. It mandates public and agency reporting on approval/denial rates, use of automated decision technology, turnaround times, appeals, and grievances; directs MedPAC, GAO, CMS, and ONC studies and reports; and gives the HHS Secretary authority to set response timeframes and enforcement for prior authorization decisions.
Left emphasizes patient access and AI oversight; right emphasizes regulatory burden.
Relative to its intended legislative type, this bill is a substantive statutory amendment that provides a detailed framework for changing prior authorization practices in Medicare Advantage through electronic prior authorization, transparency, enrollee protections, and mandated reporting and study.
The bill requires Medicare Advantage (MA) plans that use prior authorization to implement standardized electronic prior authorization (ePA) by 2028, meet transparency reporting by 2027, and adopt enrollee protection standards.
It mandates public and agency reporting on approval/denial rates, use of automated decision technology, turnaround times, appeals, and grievances; directs MedPAC, GAO, CMS, and ONC studies and reports; and gives the HHS Secretary authority to set response timeframes and enforcement for prior authorization decisions.
Moderate chance: non-ideological and beneficiary-facing but creates regulatory burdens insurers may resist; success depends on negotiated rulemaking and industry accommodation.
Relative to its intended legislative type, this bill is a substantive statutory amendment that provides a detailed framework for changing prior authorization practices in Medicare Advantage through electronic prior authorization, transparency, enrollee protections, and mandated reporting and study.
Left emphasizes patient access and AI oversight; right emphasizes regulatory burden.
These are examples from the analysis, not a ranked list of the most-affected groups.
Left emphasizes patient access and AI oversight; right emphasizes regulatory burden.
Likely views the bill favorably as a patient-access and accountability measure that curbs delays in care and increases transparency.
They will welcome oversight of automated decision tools and reporting of denials, appeals, and turnaround times.
Generally supportive but pragmatic; sees standardization and transparency as useful while wary about operational costs and feasibility.
Will emphasize need for clear deadlines, reasonable implementation timelines, and careful rulemaking to avoid unintended disruptions.
Likely skeptical; views the bill as federal micromanagement imposing mandates and administrative burden on private Medicare Advantage plans.
Concerned about increased regulation, compliance costs, and limits on plan flexibility to manage care.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Moderate chance: non-ideological and beneficiary-facing but creates regulatory burdens insurers may resist; success depends on negotiated rulemaking and industry accommodation.
The bill has not accumulated any surfaced votes yet.
Left emphasizes patient access and AI oversight; right emphasizes regulatory burden.
Moderate chance: non-ideological and beneficiary-facing but creates regulatory burdens insurers may resist; success depends on negotiated r…
Relative to its intended legislative type, this bill is a substantive statutory amendment that provides a detailed framework for changing prior authorization practices in Medicare Advantage through electronic prior auth…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.